Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 5—May 2002
Research

Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium

Morten Helms*, Pernille Vastrup*, Peter Gerner-Smidt*, and Kåre Mølbak*Comments to Author 
Author affiliations: *Statens Serum Institut, Copenhagen, Denmark;

Main Article

Table 1

The distribution of comorbidity diagnosis of 2,047 patients with S. Typhimurium infection and a sample of the general Danish population of 20,456 persons

Diagnostic group No. (%) of S. Typhimurium patients No. (%) in the general population Severity score (weight) in comorbidity index
Lymphoma or leukemia 19 (0.9) 23 (0.1) 3.40
Metastatic cancers 8 (0.4) 19 (0.1) 2.02
Liver disease 10 (0.5) 35 (0.2) 1.97
Tuberculosis 0 13 (0.1) 1.78
Movement disorders and epilepsy 4 (0.2) 40 (0.2) 1.56
Diabetes 44 (2.2) 186 (0.9) 1.50
Renal disease 31 (1.5) 114 (0.6) 1.37
Inflammatory bowel disease 39 (2.4) 66 (1.7) 1.34
Other neurologic diseasesa 12 (0.6) 76 (0.4) 1.32
Hemoglobin abnormalities 14 (0.7) 62 (0.3) 1.23
Congestive heart failure 22 (1.1) 103 (0.5) 1.22

aNeurologic or neuromuscular diseases other than Alzheimer's disease, multiple sclerosis, Parkinson's disease, Huntington's disease, and epilepsy.

Main Article

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external